Tumor-inhibiting ruthenium complexes are presented as potential anti-cancer drugs. Their galenic formulations are given and hydrolytic reactions are highlighted. Interactions of Ru(III) complexes with serum protein and with oligo- and polynucleotides are discussed.
CITATION STYLE
Pieper, T., & Keppler, B. K. (1998). Tumor-inhibiting ruthenium complexes -formulation and analytical characterization. Analusis, 26(6), 84–90. https://doi.org/10.1051/analusis:199826060084
Mendeley helps you to discover research relevant for your work.